Skip to content

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

A Pilot Study Examining the Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03837392
Enrollment
30
Registered
2019-02-12
Start date
2020-06-01
Completion date
2023-06-30
Last updated
2023-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal Anxiety, Perinatal Depression, Post Partum Anxiety, Post Partum Depression

Keywords

Pregnancy, Mental Health

Brief summary

This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Participants should expect their participation in the study to last 9-12 months.

Detailed description

The study's major theme is to examine the efficacy of a brief Acceptance and Commitment Therapy (ACT) intervention in treating perinatal anxiety symptoms, as compared to a supportive control condition. The perinatal and postpartum periods are known to be a vulnerable time for the development of mental health symptomatology, with approximately 7% of women developing postpartum depression in the first three months following childbirth. One known predictor of postpartum depression is perinatal anxiety and distress. The impact of postpartum depression extends beyond the mother, whose distress and daily functioning are affected, with adverse effects on infant development and care. The need for interventions and preventive interventions has been widely indicated for over two decades. This protocol will describe two conditions, the effects of which will be contrasted to determine the efficacy of ACT in treating anxiety and depressive symptoms among perinatal women. The ACT condition will be compared to a supportive psychoeducation intervention. The effects of the intervention will be determined in terms of self-report measures (anxiety and depressive symptoms, flexibility, mindfulness, social satisfaction) and diagnostic interviews (depression, anxiety). The impact of trauma history and psychodiagnostic history will be examined as moderating factors and/or covariates in the examination of the intervention's efficacy. This protocol will test the hypothesis that ACT is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Second, the investigators will examine the intergenerational impact of the intervention on the offspring via offspring birth outcomes, as reported in the electronic medical record. Finally, the investigators will explore mediators and moderators of the treatment outcomes. This work will advance the understanding of the impact of brief interventions on perinatal well-being and improve the ability to disseminate empirically supported interventions for pregnant mothers.

Interventions

DIAGNOSTIC_TESTBaseline Assessment (18-26 weeks pregnant)

At baseline, participants will complete several interviews and questionnaires online and via phone to determine psychological history, current functioning, history of trauma, coping styles, and demographic variables.

BEHAVIORALOnline Intervention and Phone Coaching Interventions

ACT is a cognitive-behavioral therapy that seeks to promote psychological flexibility. The active comparator is the Supportive Control. Two phone coaching sessions will occur 2- and 4-weeks post-intervention in both conditions.

DIAGNOSTIC_TESTFollow Up Assessments: 34-36 weeks pregnant and 4-week postpartum

The follow-up assessments at 34-36 weeks pregnancy and 4-weeks postpartum will be completed via REDCap, an online secure survey platform in order to reduce participant burden.

DIAGNOSTIC_TESTFollow Up Assessments: 8 weeks postpartum

The follow-up assessment at 8-weeks postpartum will be completed via phone.

Sponsors

University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Adult women (ages 18-45) who are between 18-26 weeks pregnant 2. Fluency in English 3. Ability to give informed consent and comply with study procedures (including phone and internet access) 4. Elevated GAD-7 score (10+) 5. Women must be receiving prenatal care 6. Singleton pregnancy

Exclusion criteria

1. Prisoners 2. Inability to give informed consent and comply with study procedures 3. Past/current mania, past/current psychoses (assessed with Psychosis Screening Questionnaire) 4. No therapy appointments in last 60 days (not currently in psychotherapy).

Design outcomes

Primary

MeasureTime frameDescription
Change in Inventory of Mood and Anxiety Symptoms (IMAS-R) scores from BaselinePast 1 monthThe IMAS-R provides continuous and diagnostic scores on mood, anxiety, and distress symptoms.

Secondary

MeasureTime frameDescription
Change in Five Facet Mindfulness Questionnaireup to 12 monthThis assessment is a 39-item measure where the scale is from 1 (never or rarely true) to 5 (very often or always true). FFMQ measures five facets of mindfulness with respect to one's own experience: observing (8 items), describing (8 items), acting with (8 items), non-judging (8 items), and non-reacting (7 items).
Change in Acceptance and Action Questionnaire (AAQ-2) from Baselineup to 12 monthAAQ-2 will be used to measure psychological inflexibility, avoidance behavior, and maladaptive coping. This is a 7 item measure with a scale of 1 (never true) to 7 (always true). Lower scores indicate lesser experiential avoidance.

Other

MeasureTime frameDescription
Differences in Infant Birth OutcomesAfter deliveryInfant birth outcomes will be obtained from medical records

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026